Ottawa Hospital Research Institute

Newsroom


	OHRI welcomes new board members August 15, 2025 - The Ottawa Hospital Research Institute (OHRI) is pleased to welcome two members to its Board of Directors.


	Mild hormone imbalances can have a big impact on hypertension and cardiovascular disease August 15, 2025 - A new study led by researchers at The Ottawa Hospital has shown for the first time that even mild imbalances with the hormone aldosterone are associated with a higher risk of major cardiovascular complications such as heart attack, heart failure, ...


	Hope for Huntington’s: New gene-targeted therapy trial opens in Ottawa August 7, 2025 - The Ottawa Hospital’s Parkinson’s Disease and Movement Disorders clinic is bringing new hope to people with Huntington’s disease (HD) through an innovative clinical trial of a gene-targeted therapy.


	Researchers at The Ottawa Hospital awarded 10 CIHR grants worth more than $7 million July 21, 2025 - Researchers at The Ottawa Hospital have been awarded more than $7 million from the Canadian Institutes of Health Research (CIHR) to lead 10 cutting-edge research projects.


	The Ottawa Hospital joins landmark bipolar disorder research network BD2 July 8, 2025 - The Ottawa Hospital’s Research Institute has been awarded US$ 2.3 million to join Breakthrough Discoveries for thriving with Bipolar Disorder (BD²).

See all news items \| See only press releases \| Search for news and experts by disease / specialty

Media contacts

Jennifer Ganton
Director, Communications and Public Relations,
613-614-5253
jganton@ohri.ca